CIK 0001579428
- Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454241907
- Phone
- +1 212-332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Saad Mark E Director | Option exercise | +1,429 | 11,431 | ||
| 2026-06-08 | Saad Mark E Director | Option exercise · Restricted Stock Units | −1,429 | 0 | ||
| 2026-06-05 | Saad Mark E Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2025-12-31 | Saad Mark E Director | Option exercise 10b5-1 | +6,231 | $8.02 | $50K | 16,233 |
| 2025-12-31 | Saad Mark E Director | Sale 10b5-1 | −6,231 | $165.18 | $1.0M | 10,002 |
| 2025-12-31 | Saad Mark E Director | Option exercise 10b5-1 | +31,346 | $4.95 | $155K | 41,348 |
| 2025-12-31 | Saad Mark E Director | Sale 10b5-1 | −31,346 | $165.18 | $5.2M | 10,002 |
| 2025-12-31 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,231 | 0 | ||
| 2025-12-31 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −31,346 | 0 | ||
| 2025-09-05 | Saad Mark E Director | Option exercise 10b5-1 | +9,127 | $9.00 | $82K | 19,129 |
| 2025-09-05 | Saad Mark E Director | Sale 10b5-1 | −9,127 | $125.07 | $1.1M | 10,002 |
| 2025-09-05 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,127 | 0 | ||
| 2025-06-06 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +3,166 | 3,166 | ||
| 2025-06-06 | Saad Mark E Director | Grant or award · Restricted Stock Units | +1,429 | 1,429 | ||
| 2025-02-21 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +1,494 | 1,494 | ||
| 2024-09-11 | Saad Mark E Director | Option exercise 10b5-1 | +11,016 | $3.67 | $40K | 21,018 |
| 2024-09-11 | Saad Mark E Director | Sale 10b5-1 | −11,016 | $91.31 | $1.0M | 10,002 |
| 2024-09-11 | Saad Mark E Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,016 | 0 | ||
| 2024-06-07 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 | ||
| 2024-02-27 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +1,519 | 1,519 |
Page 1 of 3 · 43 trades